JP2002510645A5 - - Google Patents

Download PDF

Info

Publication number
JP2002510645A5
JP2002510645A5 JP2000542031A JP2000542031A JP2002510645A5 JP 2002510645 A5 JP2002510645 A5 JP 2002510645A5 JP 2000542031 A JP2000542031 A JP 2000542031A JP 2000542031 A JP2000542031 A JP 2000542031A JP 2002510645 A5 JP2002510645 A5 JP 2002510645A5
Authority
JP
Japan
Prior art keywords
composition
ifn
gamma
cardiac hypertrophy
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000542031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002510645A (ja
JP5030329B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/006032 external-priority patent/WO1999051260A2/en
Publication of JP2002510645A publication Critical patent/JP2002510645A/ja
Publication of JP2002510645A5 publication Critical patent/JP2002510645A5/ja
Application granted granted Critical
Publication of JP5030329B2 publication Critical patent/JP5030329B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000542031A 1998-04-02 1999-03-19 心臓肥大の処置 Expired - Fee Related JP5030329B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8044898P 1998-04-02 1998-04-02
US60/080,448 1998-04-02
PCT/US1999/006032 WO1999051260A2 (en) 1998-04-02 1999-03-19 Treatment of cardiac hypertrophy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009181954A Division JP2009256375A (ja) 1998-04-02 2009-08-04 心臓肥大の処置

Publications (3)

Publication Number Publication Date
JP2002510645A JP2002510645A (ja) 2002-04-09
JP2002510645A5 true JP2002510645A5 (cg-RX-API-DMAC7.html) 2006-04-13
JP5030329B2 JP5030329B2 (ja) 2012-09-19

Family

ID=22157456

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000542031A Expired - Fee Related JP5030329B2 (ja) 1998-04-02 1999-03-19 心臓肥大の処置
JP2009181954A Pending JP2009256375A (ja) 1998-04-02 2009-08-04 心臓肥大の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009181954A Pending JP2009256375A (ja) 1998-04-02 2009-08-04 心臓肥大の処置

Country Status (17)

Country Link
US (2) US6187304B1 (cg-RX-API-DMAC7.html)
EP (2) EP1067958B1 (cg-RX-API-DMAC7.html)
JP (2) JP5030329B2 (cg-RX-API-DMAC7.html)
CN (1) CN1201814C (cg-RX-API-DMAC7.html)
AR (1) AR018174A1 (cg-RX-API-DMAC7.html)
AT (2) ATE332144T1 (cg-RX-API-DMAC7.html)
AU (1) AU757910B2 (cg-RX-API-DMAC7.html)
BR (1) BR9909422A (cg-RX-API-DMAC7.html)
CA (1) CA2325442C (cg-RX-API-DMAC7.html)
DE (2) DE69939723D1 (cg-RX-API-DMAC7.html)
DK (2) DK1067958T3 (cg-RX-API-DMAC7.html)
ES (2) ES2314786T3 (cg-RX-API-DMAC7.html)
IL (1) IL138812A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ506854A (cg-RX-API-DMAC7.html)
TW (1) TWI243682B (cg-RX-API-DMAC7.html)
WO (1) WO1999051260A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200004854B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192659A1 (en) * 1997-09-17 2002-12-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
BR9909422A (pt) * 1998-04-02 2001-09-11 Genentech Inc Método para tratamento de hipertrofia cardìaca, método para preparação de composição farmacêutica para o tratamento de hipertrofia cardìaca e seu produto farmacêutico
ATE376837T1 (de) * 1999-07-12 2007-11-15 Genentech Inc Stimulierung oder hemmung von angiogenese und herzvaskularisierung mit tumor nekrose faktor ligand/rezeptor homologen
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
US7625584B2 (en) * 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
AU2002310922A1 (en) * 2001-05-04 2002-11-18 Institute Of Molecular And Cell Biology Interferons in the treatment of ischemia
US20050079156A1 (en) * 2001-11-06 2005-04-14 Grace Wong Method of treating endometreosis
WO2003068260A1 (fr) * 2002-02-14 2003-08-21 Chugai Seiyaku Kabushiki Kaisha Produits pharmaceutiques en solution contenant des anticorps
KR101160780B1 (ko) * 2002-08-29 2012-06-27 산텐 세이야꾸 가부시키가이샤 Rho 키나아제 억제제 및 프로스타글란딘류를 포함하는 녹내장 치료제
WO2004045644A1 (ja) * 2002-11-18 2004-06-03 Santen Pharmaceutical Co., Ltd. Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤
EP1522857A1 (en) * 2003-10-09 2005-04-13 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
WO2009154770A2 (en) * 2008-06-18 2009-12-23 The Texas A & M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
USD647411S1 (en) 2011-01-12 2011-10-25 Rain Bird Corporation Water timer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096705A (en) 1981-10-19 1992-03-17 Genentech, Inc. Human immune interferon
US5582824A (en) 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
AU561343B2 (en) 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4929544A (en) 1982-04-23 1990-05-29 Sri International Reagents, methods, and test kit for diagnosing/monitoring cancer in humans
US4855238A (en) 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
US4944941A (en) 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
SE462364B (sv) 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
DK0502997T3 (da) 1989-12-01 1995-07-17 Childrens Medical Center Behandling af atopiske sygdomme med gamma-interferon
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5573762A (en) 1995-04-24 1996-11-12 Genentech, Inc. Use of leukemia inhibitory factor specific antibodies and endothelin antagonists for treatment of cardiac hypertrophy
WO1997007820A1 (fr) * 1995-08-30 1997-03-06 Toray Industries, Inc. Remede destine aux maladies cardiaques
BR9909422A (pt) * 1998-04-02 2001-09-11 Genentech Inc Método para tratamento de hipertrofia cardìaca, método para preparação de composição farmacêutica para o tratamento de hipertrofia cardìaca e seu produto farmacêutico

Similar Documents

Publication Publication Date Title
RU2355387C2 (ru) Трансдермальный гранисетрон
Haas An update on local anesthetics in dentistry
EP1280531B1 (en) Formulation consisting of phentolamine mesylate and the use thereof
Kemper et al. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial
AR026355A1 (es) Formulacion y metodo antidiabetico.
CN1185106A (zh) 咔唑化合物在治疗充血性心力衰竭中的应用
JP2005501110A5 (cg-RX-API-DMAC7.html)
RU2002114820A (ru) Способ лечения диабета
CA2325442A1 (en) Treatment of cardiac hypertrophy using interferon-gamma
JP2017132791A (ja) 組み合わせ組成物
JP2001510795A5 (cg-RX-API-DMAC7.html)
Nespeca Clinical trials with bupivacaine in oral surgery
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
Aldrete et al. Reverse carotid blood flow—a possible explanation for some reactions to local anesthetics
CN1403081A (zh) 他汀类抑制破骨细胞形成的用途
RU2002105485A (ru) Применение микофенолята мофетила в сочетании с ПЭГ-интерфероном-α (ПЭГ-IFN-α)
RU2181588C2 (ru) Способ профилактики отсроченной рвоты
JP3792251B2 (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
CA2454699A1 (en) Method for treating primary insomnia
US20210046025A1 (en) Injection for Protecting Ischemic Myocardium and Preparation Method thereof
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
Østergaard et al. Intra-articular corticosteroids in arthritic disease: a guide to treatment
ES2210025T3 (es) Agente farmaceutico para el tratamiento de estados convulsivos.
CA2368352A1 (en) Method for treating neurodegeneration
Needleman et al. The use of epsilon-aminocaproic acid for the management of hemophilia in dental and oral surgery patients